BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3456279)

  • 1. Susceptibility of the human promyelocytic cell line HL-60 to an endogenous antileukaemic factor in suspension cultures.
    Balázs A; Tapolcai A; Hetényi G; Mann J; Boldog F
    Cell Biol Int Rep; 1986 Jan; 10(1):1-9. PubMed ID: 3456279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
    Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
    Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a regulatory peptide distinct from normal granulocyte-derived hemoregulatory peptide produced by human promyelocytic HL-60 leukemia cells after differentiation induction with retinoic acid.
    Paukovits JB; Paukovits WR; Laerum OD
    Cancer Res; 1986 Sep; 46(9):4444-8. PubMed ID: 3460696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antimetabolites and thymidine blockage on the induction of differentiation of HL-60 cells by retinoic acid or 1 alpha,25-dihydroxyvitamin D3.
    Ishikura H; Okazaki T; Mochizuki T; Izumi Y; Tashima M; Sawada H; Uchino H
    Exp Hematol; 1985 Nov; 13(10):981-8. PubMed ID: 3932088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of HL-60 monocytic cell differentiation promoted by a perturbation of DNA synthesis: hydroxyurea promotes action of TPA.
    Yen A; Freeman L; Fishbaugh J
    Exp Cell Res; 1988 Jan; 174(1):98-106. PubMed ID: 2826198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation by 1-alpha,25-dihydroxyvitamin D3 of cytotoxicity to HL-60 cells produced by cytarabine and hydroxyurea.
    Studzinski GP; Bhandal AK; Brelvi ZS
    J Natl Cancer Inst; 1986 Apr; 76(4):641-8. PubMed ID: 3457201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of conditioned medium upon proliferation, deoxynucleotide metabolism, and antimetabolite sensitivity of promyelocytic leukemic cells in vitro.
    Elias L; Wood A; Crissman HA; Ratliff R
    Cancer Res; 1985 Dec; 45(12 Pt 1):6301-7. PubMed ID: 3864529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
    Rauscher F; Cadman E
    Cancer Res; 1983 Jun; 43(6):2688-93. PubMed ID: 6189585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human GM-CSF significantly enhances the cytostatic activity of cell cycle specific anti-leukaemic drugs in HL-60 human myeloid leukaemia clonogenic cells in a capillary clonogenic micro-assay.
    Hassan HT; Veit A; Maurer HR
    Anticancer Res; 1991; 11(1):481-5. PubMed ID: 2018385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nardostachys chinensis induces granulocytic differentiation with the suppression of cell growth through p27(Kip1) protein-related G0/G1 phase arrest in human promyelocytic leukemic cells.
    Ju SM; Lee J; Kang JG; Jeong SO; Park JH; Pae HO; Lee GS; Kim WS; Lyu YS; Jeon BH
    Pharm Biol; 2015 Jul; 53(7):1002-9. PubMed ID: 25430995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nicotine on cellular proliferation, cell cycle phase distribution, and macromolecular synthesis in human promyelocytic HL-60 leukemia cells.
    Konno S; Chiao JW; Wu JM
    Cancer Lett; 1986 Oct; 33(1):91-7. PubMed ID: 3464351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
    Schwartz EL; Blair OC; Sartorelli AC
    Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the G1 arrest position of senescent WI38 cells by quinacrine dihydrochloride nuclear fluorescence. Evidence for a late G1 arrest.
    Gorman SD; Cristofalo VJ
    Exp Cell Res; 1986 Nov; 167(1):87-94. PubMed ID: 3758211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
    Vilpo JA; Vilpo LM
    Cancer Res; 1988 Jun; 48(11):3117-22. PubMed ID: 3163271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell kill kinetics with hydroxyurea.
    Yataganas X; Strife A; Perez A; Clarkson B
    Med Pediatr Oncol; 1976; 2(1):39-54. PubMed ID: 1064742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of cell differentiation during proliferation. II. Myeloid differentiation and cell cycle arrest of HL-60 promyelocytes preceded by nuclear structural changes.
    Yen A; Reece SL; Albright KL
    Leuk Res; 1985; 9(1):51-71. PubMed ID: 3857406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for cell cycle phase-specific initiation of a program of HL-60 cell myeloid differentiation mediated by inducer uptake.
    Yen A; Albright KL
    Cancer Res; 1984 Jun; 44(6):2511-5. PubMed ID: 6327017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the effect of 1,25-dihydroxycholecalciferol on the proliferation and differentiation of the human promyelocytic leukaemia cell line HL-60.
    Djulbegović B; Christmas SE; Evans G; Moore M
    Biomed Pharmacother; 1986; 40(10):407-16. PubMed ID: 3472610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of monocytic differentiation by calcitriol (1,25-dihydroxyvitamin D3) in the human promyelocytic leukemic cell line (HL-60) in serum-free medium.
    Lee Y; Dunlap BE; Mellon WS
    Biochem Pharmacol; 1987 Nov; 36(22):3893-901. PubMed ID: 2825707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of prostaglandin A2 on c-myc expression and cell cycle progression in human leukemia cell line HL-60.
    Ishioka C; Kanamaru R; Sato T; Dei T; Konishi Y; Asamura M; Wakui A
    Cancer Res; 1988 May; 48(10):2813-8. PubMed ID: 3162825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.